Table 1.
Session | ||||
---|---|---|---|---|
1 y dosing | 2 y dosing | 1 y post-dosing | ||
Nighttime active periods (#) | Veh | 52±2 | 54±2 | 54±3 |
Flx | 55±1§ | 58±2 | 63±2* | |
Nighttime rest duration (min) | Veh | 779±34 | 839±35 | 783±35 |
Flx | 763±20 | 793±27 | 674±33* | |
Time to first rest period at night (min) |
29±3 23±3 |
39±4 32±4 |
49±4 40±3 |
|
Daytime rest duration (min) | Veh | 32±8 | 99±12 | 175±20 |
Flx | 70±16* | 123±14 | 161±19 | |
Daytime activity during rest periods (activity counts) |
Veh | 4.5±0.5 | 5.6±0.4 | 3.1 ±0.2 |
Flx | 3.8±0.5 | 4.6±0.2* | 2.4±0.1** |
fluoxetine*MAOA interaction p=.03, hi-MAOA Flx vs Veh p=.02
p<.05,
p<.02 main effect of fluoxetine